Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/q/polya/) was not found.

Search q polya at Google

Search q polya at Yahoo

Search q polya at Msn

Google
 
(Date:10/10/2008)...obal, will be the focus of the Society for Nutriti...ngle event is just one small step in fighting worl...und the world and requires immediate attention in ...ion, hunger and deficiencies. The Society for Nutr...he public to get involved and make a difference in...
(Date:10/9/2008)...PRNewswire-FirstCall/ -- Synaptics(R),Incorporated...terface,solutions for mobile computing, communicat...hat it will report financial results for the first...008 after the close of market. The,company will ho...d,investors at 2:00 p.m. PT (5:00 p.m. ET) during ...
(Date:10/9/2008)...an Molecular Biology Laboratory (EMBL) have genera...e developmental blueprint of a vertebrate. With a ...e first time track all cells for the first 24 hour...ructed into a three-dimensional, digital represent...urrent online issue of Science , grants many new ...
(Date:10/9/2008)... role in anencephaly, offering hope for a genetic ...ct in which the brain fails to develop, according ...llinois at Chicago College of Medicine. , The st... Molecular Endocrinology . , In the U.S., 1,00... year. Most do not survive more than a day or two....
Breaking Biology News(10 mins):World Food Day brings attention to food security around the globe 2Synaptics to Report First Quarter Results on October 23 2Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate 2Clue to genetic cause of fatal birth defect 2Working Hard When Tired Raises Blood Pressure 23277 1Working Hard When Tired Raises Blood Pressure 23277 2Kings County Death 3A NAMI Calls for Criminal Probe 3B Survey Shows Psychiatric Emergency Room Delays Are National Problem 23272 1Kings County Death 3A NAMI Calls for Criminal Probe 3B Survey Shows Psychiatric Emergency Room Delays Are National Problem 23272 2SIDS Linked to Brain Chemical Dysfunction 23269 1SIDS Linked to Brain Chemical Dysfunction 23269 2SIDS Linked to Brain Chemical Dysfunction 23269 3Species have come and gone at different rates than previously believed 3896 1Species have come and gone at different rates than previously believed 3896 2Species have come and gone at different rates than previously believed 3896 3
...ths, the IODP Arctic Coring Expedition (ACEX) is m...nts. In the Aug. 10 issue of Nature, an article by...heir findings: more evidence that the Arctic was e...he time the last massive amounts of greenhouse gas...riod calculated to have occurred 55 million years ...
... designated Special Areas of Conservation througho..., might be at risk from pile driving. The frequenc... their ability to communicate, find food and avoid... behaviour, health and their ability to breed succ... be particularly vulnerable , Recently more than ...
...nce suggesting an alternative form of natural vita...od in humans at levels determined to protect again... naturally in eight different forms. The primary v..., or TCP. But another natural form of vitamin E su...ted Ohio State University Medical Center studies i...
...,d all agree it,s not worthless. So, what,s the pr..., the University of Vermont,s Robert Costanza and ...year in a now-famous paper in the journal Nature. ... services" has bloomed. This young discipline stud...ormation, crop pollination, flood protection, and ...
Other Biology News:Arctic coring expedition continues to yield new clues 2Dolphins at risk 2Natural vitamin E tocotrienol reaches blood at protective levels 2Natural vitamin E tocotrienol reaches blood at protective levels 3What's nature worth? New computer models tell all 2
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...recent study has revealed that heart patients who ...n times higher a chance of receiving a jolt from t...hm than nonsmokers with the device. // The study ...chool of Medicine in St. Louis .Eleven percent of ...
...cording to a study in UK it was found that de- add...onal Institutes of Health analyzed 1,383 people wi...sort of drug. The study results were reported in t...This drug can be made accessible easily to all peo...
...cording to figures from the Human Fertility and E...s an increase in the rates of women attaining moth...s seen that in 1992, just one baby was born to a m...e born to women in that age group after IVF treatm...
...leading cardinal has urged Christians to initiate ...ci Code" book and film as he feels that it offends...ust not just sit back and say it is enough for us ...is Arinze. The novel is based on attempts to disc...
Other Medicine News:Health News:Jolt to Quit Smoking 2
GOAT ANTI FRK
II Plate Washer (Plum) from GE Healthcare, formerly Amersham Biosciences
...mplementary RNA Spikes for the normalization and c...ray printing and for protocol assessment and optim...abeling, hybridization stringency and background. ...and Oligo Spots, and complementary RNA Spikes for ...
MOUSE ANTI DUCK IgY LIGHT CHAIN
Biology Products:
For complete orthopedic trauma procedures. Part of the osi modular table system, the orthopedic trauma table top provides a complete, powered, orthopedic table for easy patient positioning and provid
...battery-powered medical devices indicated for use ...union fracture acquired secondary to trauma, exclu...cal studies have shown an increased chance of heal...ged 29.3 months from injury. Registry data on over...
...growth stimulation delivered by Physio-Stim is a s...ne nonunions. Physio-Stim may be worn over a cast,...ts effectiveness. Physio-Stim has everything you n...cess rates as high as 88%1, and it comes with a wr...
Linvatec cannulated interference screws have a spiral tip design to limit screw divergence. Screws are available in three diameters and five lengths. Screws are supplied sterile, complete with guidew
Medicine Products:
(Date:10/10/2008)...nty of Britain,s most,innovative technology compan...t the fifth annual SETsquared Partnership Showcase...George Street, London, from 8am on,Thursday, Octob...nnovators,in electronics, information technology, ...l give 10-minute presentations to an audience of,a...
(Date:10/10/2008)...da Pharmaceutical Company,Limited ("Takeda") today...ment Center, Inc., a wholly owned United States (U...S. Food and Drug Administration (FDA) will,not be ...Drug Application,(NDA) by the Prescription Drug Us... our most recent discussion with the FDA, it indic...
(Date:10/9/2008)...Pairing traditional quality,tools with innovations...g,are helping organizations reduce waste, meet cus...today,s market. At How Process Improvement Leaders...ality excellence,conference hosted by Best Practic...from leading companies shared results from recent ...
(Date:10/9/2008)...oss Life Sciences Industry -, ROCKLAND, Mass., Oc...e,of Merck KGaA, Darmstadt, Germany, announced tod... top employer in the biotechnology and,pharmaceuti... employers,across the life sciences., "We are hon...EMD Serono,as a leading place to work," said Bernh...
Breaking Biology Technology:Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes 2EMD Serono Named as a Top Employer by Science Magazine 2
... Key words: NK2 • GPCR • receptor ...ging Beads , , Neurokinins, also k...ptides. Members of this family include peptides, s...(NKB), and the recently discovered hemokinin-1 (1)...e central and peripheral nervous system where they...
...e Ettan™ DIGE Imager (Fig 1) is a scanning C...iences. In particular, it has been engineered to c...bining high resolution with precise motion control...nnel images of your Cy™2-, Cy3-, and Cy5-lab...ge a wide range of other fluorescent gel applicati...
...>J. Turner , GE Healthcare, The Maynard C...binding assays have been developed for measuring t...ine and tyrosine kinases. Based on enzyme fragment...chemiluminescent substrate, HitHunter™ Kinas...ther on high-throughput imaging platforms or on st...
... Key words: cAMP • GPCR • enzyme f...; assay miniaturization , , G pro...ily of transmembrane receptors and are responsible...ellular signals. Up to 40% of clinically marketed ... these drugs exhibit their activity at less than 1...
Other Biology Technology:Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System 2Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System 3Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System 4Ettan DIGE Imager 2Ettan DIGE Imager 3Homogeneous, chemiluminescent kinase assay kits for assessing the functional activity of a broad range of serine-threonine and tyrosine kinases 2Homogeneous, chemiluminescent kinase assay kits for assessing the functional activity of a broad range of serine-threonine and tyrosine kinases 3Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3', 5' monophosphate and its validation for pharmacological screening at G protein-coupled receptors 2Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3', 5' monophosphate and its validation for pharmacological screening at G protein-coupled receptors 3Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3', 5' monophosphate and its validation for pharmacological screening at G protein-coupled receptors 4Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3', 5' monophosphate and its validation for pharmacological screening at G protein-coupled receptors 5Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3', 5' monophosphate and its validation for pharmacological screening at G protein-coupled receptors 6
(Date:10/8/2008)...- Exploratory study shows clinical improvement in...n (PAH), -- Current treatment options have limi...ogressive and incurable blood vessel disease, --...reatment of certain cancers, known to inhibit...rther explore potential of imatinib mesylate in PA...
(Date:10/7/2008)...AUSTIN, Texas, Oct. 7 /- The Texas Ca...edical Center has been selected as one of,only a f...proved clinical,trial for a new device to treat pe...al treatment, training and research center special...between St. David,s Medical Center and,Texas Cardi...
(Date:10/7/2008)...VIENNA, Va., Oct. 7 /- CEL-... it has entered into a Material Transfer,Agreement...ical Center,(NIHCC) and the laboratory of Dr. Fran...ular basis of changes to the tumor microenvironmen...arincola is the Chief of,the Infectious Disease an...
(Date:10/7/2008)...CAMBRIDGE, Mass., Oct. 7 /- Taligen T... on several of the Company,s pipeline,candidates w... Workshop in,Basel, Switzerland. The data highligh...els of complement-mediated diseases., "These high... studies,presented at the conference, reveal the d...
Breaking Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4UCLA researchers clarify function of glucose transport molecule 3893 1UCLA researchers clarify function of glucose transport molecule 3893 2Medivation to Host Conference Call at 5 p m EDT Monday to Discuss Top Line Phase 2 Study Results in Huntingtons Disease 2578 1Medivation to Host Conference Call at 5 p m EDT Monday to Discuss Top Line Phase 2 Study Results in Huntingtons Disease 2578 2Freeze Dried Formula May Block HIV Virus in Breast Milk 23262 1Freeze Dried Formula May Block HIV Virus in Breast Milk 23262 2Leading Vaccine Expert Joins IAVI 23259 1Leading Vaccine Expert Joins IAVI 23259 2Leading Vaccine Expert Joins IAVI 23259 3
...s no stent thrombosis or MACE,after one year, NATI...wswire-FirstCall/ -- Boston Scientific Corporation...m the SPIRIT FIRST, II,and III Clinical Trials, re...arket-leading TAXUS(R) Express2(TM) Paclitaxel-Elu...S(TM)) Everolimus,Eluting Coronary Stent System. T...
...ation of Choroidal,Neovascularization (CNV) in an ...stCall/ -- Lpath, Inc. ,the category leader in th...d compelling proof-of-concept data in a standard a...ion (AMD). , The results were presented at the ann...on and Ophthalmology (ARVO) by Glenn,L. Stoller, M...
Other Medicine Technology:SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus,Drug-Eluting Coronary Stent Systems 2SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus,Drug-Eluting Coronary Stent Systems 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 2Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 4